Rat Pd-1 Elisa

Anti-Human PD-1, rabbit IgG
MBS432035-01mg 0.1mg
EUR 370

Human IgG antibody Laboratories manufactures the rat pd-1 elisa reagents distributed by Genprice. The Rat Pd-1 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rat elisa. Other Rat products are available in stock. Specificity: Rat Category: Pd-1 Group: Elisa

Human True insulin ELISA kit
96T
EUR 700
Description: ELISA

Human True insulin ELISA kit
192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit
1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit
48 wells plate
EUR 280

Human True insulin ELISA kit
1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True insulin ELISA kit
96 wells plate
EUR 405

Human True insulin ELISA Kit
48-Strip-Wells-(Competitive)
EUR 485

Elisa information

PD-1 [Biotinylated] : PD-L1 Inhibitor Screening ELISA Kit
EP-101-96tests 96tests
EUR 664.9
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit
EP-120 96tests
EUR 719.4
Description: PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells.

PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit
EP-120-96tests 96tests
EUR 719.4
Description: PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells.

PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit
EP-130 96tests
EUR 664.9
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit
EP-130-96tests 96tests
EUR 664.9
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-L1 : PD-1 [Biotinylated] Inhibitor Screening ELISA Kit
EP-133 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-L1 : PD-1 [Biotinylated] Inhibitor Screening ELISA Kit
EP-133-96tests 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit
EP-154 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit
EP-154-96tests 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-L1 [Biotinylated] : PD-1 Inhibitor Screening ELISA Kit
EP-158 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

PD-L1 [Biotinylated] : PD-1 Inhibitor Screening ELISA Kit
EP-158-96tests 96tests
EUR 719.4
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.

Nori Bovine PD-1 ELISA Kit
GR112064 96-well
EUR 461

Nori Canine PD-1 ELISA Kit
GR115039 96-well
EUR 461

PD-1/PDCD1 ELISA KIT|Human
EF008782 96 Tests
EUR 826.8

Human PD-1/PDCD1 ELISA Kit
MBS8123857-5x96Tests 5x96Tests
EUR 2200

Human PD-1/PDCD1 ELISA Kit
MBS8123857-96Tests 96Tests
EUR 480

Human PD-1 PicoKine ELISA Kit
MBS177236-5x96StripWells 5x96-Strip-Wells
EUR 2755